TrianglePUBLICATIONS · 21048039
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2011 May
- First author
- Licitra L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Licitra L
- type
- Author
- name
- Mesia R
- type
- Author
- name
- Rivera F
- type
- Author
- name
- Remenár É
- type
- Author
- name
- Hitt R
- type
- Author
- name
- Erfán J
- type
- Author
- name
- Rottey S
- type
- Author
- name
- Kawecki A
- type
- Author
- name
- Zabolotnyy D
- type
- Author
- name
- Benasso M
- type
- Author
- name
- Störkel S
- type
- Author
- name
- Senger S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Licitra L
- type
- Author
- name
- Mesia R
- type
- Author
- name
- Rivera F
- type
- Author
- name
- Remenár É
- type
- Author
- name
- Hitt R
- type
- Author
- name
- Erfán J
- type
- Author
- name
- Rottey S
- type
- Author
- name
- Kawecki A
- type
- Author
- name
- Zabolotnyy D
- type
- Author
- name
- Benasso M
- type
- Author
- name
- Störkel S
- type
- Author
- name
- Senger S
- type
- Author
- bibliography ids
- nci-bib-4ee1d959da036b35cbb38995
- book metadata
- content sha256
- 9f18f0b3dcb85099cc404b541b41ee999376922497affc422b3dbf5914becc62
- document type
- citation
- dois
- 10.1093/annonc/mdq588
- electronic publication date
- display
- 2010 Nov 3
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21048039
- immutable id
- pubmed:21048039@9f18f0b3dcb85099cc404b541b41ee999376922497affc422b3dbf5914becc62
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 5
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1078-1087
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21048039
- provenance
- batch id
- 10a38257e12e9ed1867a
- provider
- NCBI PubMed ESummary
- record sha256
- 92d721b4033fa9f01f0c0a3b67e98172b001f8710d24392e7552f57763aac5b5
- response sha256
- 84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
- retrieved at
- 2026-09-09T23:46:35.793530+00:00
- publication date
- display
- 2011 May
- precision
- month
- year
- 2011
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Preserved source evidence · Not medical advice